Molecule discovery shows promise for psoriasis gene therapies
Scientists at the University of Birmingham have announced the discovery of a protein that could hold the key to novel gene therapies for skin problems such as psoriasis.
Read More
Author: Anna Smith
New clinical trial reduces breast cancer radiotherapy side effects
A practice-changing new clinical trial has been found to reduce long-term radiotherapy side effects in women with breast cancer.
Read More
Gilead & Agenus form $1.8bn partnership
Gilead Sciences and Agenus have announced a partnership to focus on the development and commercialisation of up to five novel immuno-oncology therapies.
Read More
Health industry responds to Immigration White Paper
Proposed new post-Brexit immigration rules have been released by the Home Secretary, which set out plans for a new single, skills-based immigration system, marking the end of free movement.
Read More
NICE publishes updated guidance with expanded recommendation for Oncotype DX
The National Institute for Health and Care Excellence (NICE) has announced the release of a second set of guidelines recommending three tests as options to help NHS clinicians decide whether to prescribe chemotherapy for some people with early breast cancer.
Read More- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
